The 20 Best HER2 Negative Breast Cancer Doctors Near Me in Teaneck, NJ

Ami Vaidya is a Surgical Oncologist practicing medicine in Hackensack, New Jersey. Dr. Vaidya is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Vaidya is board certified in American Board Of Obstetrics And Gynecology.

Karen Patrusky is an Obstetrics and Gynecologist practicing medicine in Englewood, New Jersey. Dr. Patrusky is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Pelvic Inflammatory Disease, Zoon Vulvitis, Vulvovaginitis, Bowenoid Papulosis, and Intrauterine Device Insertion. Dr. Patrusky is board certified in American Board Of Obstetrics And Gynecology.

Troy Callahan is a Plastic Surgeon practicing medicine in Hackensack, New Jersey. Dr. Callahan is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Breast Enlargement In Males, Keloids, BRCA Positive Breast Cancer, and HER2 Negative Breast Cancer. Dr. Callahan is board certified in American Board Of Plastic Surgery. Dr. Callahan is currently accepting new patients.

Kari Colen is a Plastic Surgeon practicing medicine in Hackensack, New Jersey. Dr. Colen is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Breast Enlargement In Males, Keloids, Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, and Hernia Surgery. Dr. Colen is board certified in American Board Of Plastic Surgery.

Adam Feintisch is a Plastic Surgeon practicing medicine in Maywood, New Jersey. Dr. Feintisch is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. His clinical expertise encompasses Basal Cell Skin Cancer, Ganglion Cyst, Breast Enlargement In Males, and Carpal Tunnel Syndrome. Dr. Feintisch is board certified in American Board Of Plastic Surgery. Dr. Feintisch is currently accepting new patients.

Michael Goldman is an Endocrinologist practicing medicine in Englewood Cliffs, New Jersey. Dr. Goldman is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. His clinical expertise encompasses Thyroid Nodule, BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, and Osteoporosis.

Katherine D. Crew, M.D., M.S. is an the Avon Products Foundation Professor of Medicine and Epidemiology at the NewYork-Presbyterian/Columbia University Medical Center, co-associate director for education and training and co-director of the Cancer Research Training and Education Core (CRTEC) at the Herbert Irving Comprehensive Cancer Center (HICCC). In addition to treating patients with breast cancer and women at high-risk for breast cancer, Dr. Crew has a long-standing interest and background in the design of clinical trials and observational studies in breast cancer prevention and survivorship.She serves as the Director of the Clinical Breast Cancer Prevention Program at Columbia University and Executive Officer for the SWOG Prevention, Screening, and Surveillance and Cancer Care Delivery Committees. She is a member of multiple national consortia and societies in oncology, including the American Association for Cancer Research and American Society of Clinical Oncology, and is an editorial board member of the Journal of Clinical Oncology. Dr. Crew received her undergraduate B.S. in Biochemistry from Brown University, where she graduated Magna Cum Laude. She received her M.D. from Columbia University College of Physicians and Surgeons and her M.S. from Columbia University School of Public Health. She completed her Internal Medicine residency and Medical Oncology fellowship at NewYork-Presbyterian/Columbia University Medical Center. Dr. Crew is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Salpingo-Oophorectomy. Dr. Crew is board certified in Internal Medicine and Medical Oncology. Dr. Crew is currently accepting new patients.

Dr. Hershman is Witten Family Professor of Medicine, American Cancer Society Professor of Medicine and Epidemiology, chief of the division of hematology/oncology, and deputy director of the Herbert Irving Comprehensive Cancer Center at Columbia University. She completed her medical degree at the Albert Einstein College of Medicine, and completed her internal medicine and oncology fellowship training at Columbia University Medical Center, where she served as Chief Resident. During that time she completed a Master's degree in Biostatistics at the Mailman School of Public Health. She has developed nationally recognized expertise in breast cancer treatment, prevention, and survivorship.Dr. Hershman has also developed a comprehensive multidisciplinary program to study ways of improving cancer care delivery (CCD), reducing disparities and designing studies to improve the quality of life and quality of care in breast cancer survivors. She has received funding from the American Society of Clinical Oncology, American Cancer Society, Department of Defense, Breast Cancer Research Foundation, PCORI, and the National Cancer Institute. She currently has mentored numerous faculty members who have been granted mentored career development awards, and has received the Women Who Conquer Cancer Mentorship Award and the CUIMC Mentor of the Year Award. Dr. Hershman has published over 450 scientific articles and has received several awards including the highly prestigious Advanced Clinical Research Award in Breast Cancer from the American Society of Clinical Oncology, the Advanced Medical Achievement Award from the Avon Foundation and a Giants in Cancer Care Award.She has several national leadership roles in oncology. As vice chair of the SWOG Cancer Research Network she oversees the NCI's Community Oncology Research Programs (NCORP) research portfolio, which includes prevention and epidemiology, cancer care delivery, symptom control and quality of life, and survivorship trials. Within ASCO she was selected to participate in the first Leadership Development Program and has been the Chair of the Grants Selection Committee, Chair of the ASCO Quality Care Symposium and has been a member of multiple committees and task-forces. She is on the editorial board for the Journal of Clinical Oncology and is an Associate Editor at the Journal of the National Cancer Institute. Dr. Hershman is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Febrile Neutropenia, Inflammatory Breast Cancer, Vulvectomy, and Salpingo-Oophorectomy. Dr. Hershman is board certified in Internal Medicine and Medical Oncology. Dr. Hershman is currently accepting new patients.

June Y. Hou, MD is an Associate Professor of Obstetrics & Gynecology at the Columbia University Medical Center. Dr. Hou received her undergraduate degree at Yale College with Honors, and completed medical school at Georgetown University School of Medicine. After completing her residency training at Yale New Haven Hospital, she pursued a gynecologic oncology fellowship at Albert Einstein College of Medicine, Montefiore Medical Center. She is board certified in Obstetrics and Gynecology and Gynecologic Oncology, and also has a Master Degree of Business Administration from Columbia Business School.She joins the faculty at Columbia University Medical Center with a research interest in promoting equity and diversity in clinical trials, and quality of life measures in clinical trial participants. Her clinical interest encompasses expanding awareness of heredity gynecological cancers and access to care, along with clinical outreach. A past recipient of a career development grant focusing on molecular pathogenesis of ovarian cancer and rare uterine cancers, Dr. Hou has given numerous nationally-recognized presentations based on her work, and has led numerous clinical trials. Clinically, Dr. Hou is certified in minimally invasive surgery, including robotic-assisted surgery. Her expertise includes novel and traditional chemotherapeutics and complex pelvic surgeries. Her goal is to provide compassionate and individualized care to all women with pre-malignant or gynecological cancers. Dr. Hou is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Sertoli-Leydig Cell Tumor, Hysterectomy, and Oophorectomy. Dr. Hou is board certified in Obstetrics And Gynecology and Hospice And Palliative Medicine. Dr. Hou is currently accepting new patients.

Fay Kastrinos is a Medical Genetics specialist and a Gastroenterologist practicing medicine in New York, New York. Dr. Kastrinos is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Familial Colorectal Cancer, Colonoscopy, and Endoscopy. Dr. Kastrinos is board certified in Gastroenterology. Dr. Kastrinos is currently accepting new patients.

Meghna S. Trivedi, MD, MS cares for patients diagnosed with breast cancer. Dr. Trivedi received her medical degree from the University of Maryland School of Medicine, and completed her residency at the University of Pennsylvania. She went on to complete her fellowship in hematology/oncology at Columbia University.Dr. Trivedi co-leads the Hereditary Breast and Ovarian Cancer Program, a comprehensive, multi-disciplinary initiative aimed at screening, preventing, diagnosing, and treating hereditary breast and ovarian cancer. This innovative program brings together the resources of a world-renowned academic institution, including cutting-edge genomic testing, clinical trials, and experts in hereditary cancers across different specialties.Dr. Trivedi’s research and care expertise also includes cancer genetics and genomics, precision medicine, and chemotherapy induced peripheral neuropathy. She is the principal investigator on several clinical trials, and has authored numerous publications in leading peer-reviewed journals. Dr. Trivedi is a member of the American Society of Clinical Oncologists and SWOG. Dr. Trivedi is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Salpingo-Oophorectomy, and Thrombectomy. Dr. Trivedi is board certified in Internal Medicine. Dr. Trivedi is currently accepting new patients.

Lisa Wiechmann is a General Surgeon practicing medicine in New York, New York. Dr. Wiechmann is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Lymphadenectomy, and Mastectomy. Dr. Wiechmann is board certified in Surgery. Dr. Wiechmann is currently accepting new patients.

Erika Brinkmann is a General Surgeon practicing medicine in Teaneck, New Jersey. Dr. Brinkmann is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Intraductal Papilloma, Breast Cancer, Fibroadenoma, and Lymphadenectomy.

Dr. Delia Keating is a board-certified radiologist specializing in breast imaging. She is an associate professor of radiology at the Columbia University Vagelos College of Physicians and Surgeons and the director of the Avon Foundation Breast Imaging Center. Dr. Keating is experienced in all types of breast imaging and breast cancer diagnosis, including mammography, ultrasound, and MRI, as well as image-guided interventional procedures such as stereotactic breast biopsy, ultrasound-guided biopsy, MR-guided biopsy, and preoperative image-guided localizations. Dr Keating’s primary area of interest is multimodality screening for breast cancer. She previously served as medical director of the Guttman Diagnostic Center at Memorial Sloan Kettering Cancer Center and as a member of the Clinical Advisory Board of the Breast Examination Center of Harlem. She has served as president of the New York Breast Imaging Society. Dr Keating is an experienced educator and trains and supervises fellows, residents and observers in all aspects of breast imaging and intervention and has received awards for excellence in teaching.Dr. Keating received her medical degree from Northwestern University Feinberg School of Medicine and completed her residency training at University of Pittsburgh Medical Center, followed by a breast imaging fellowship at University of California at San Francisco. Dr. Keating is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Breast Lump, Cystic Fibrosis, Lymphoid Hyperplasia, and Galactocoele.

Dr. Katja Pinker-Domenig is an internationally renowned physician-scientist and board-certified radiologist with expertise in breast imaging. She is a professor of radiology at Columbia University Irving Medical Center and chief of the Division of Breast Imaging. She is an attending radiologist at NewYork-Presbyterian Hospital. Dr. Pinker-Domenig has extensive expertise in all aspects of state-of-the-art breast imaging and interventions, including mammography, digital breast tomosynthesis, ultrasound, MRI, and biopsy procedures.She is widely recognized for her pioneering work advancing the field of breast MRI through the development, improvement, and implementation of multiparametric MRI (which give more detailed pictures) into routine patient care, enabling the most accurate breast cancer detection. Her current research is focused on advanced functional multimodality breast imaging and the implementation of artificial intelligence into breast imaging with the goal of enabling personalized medicine in breast care.Dr. Pinker-Domenig is the author of more than 200 peer-reviewed papers in prestigious journals, and she has been recognized with numerous awards. She is the editor-in-chief of the British Journal of Radiology Open, deputy editor of the Journal of Magnetic Resonance Imaging and section editor and reviewer for numerous medical journals.After studying medicine at the Medical University of Vienna, Austria, Dr. Pinker-Domenig completed a residency in radiology in the Department of Biomedical Imaging and Image-Guided Therapy at the Medical University of Vienna, Austria. She then completed a research fellowship at Barts and the London School of Medicine and Princess Grace Hospital in London, UK, and obtained a PhD at the Medical University of Vienna, as well as earning the European Diploma in Breast Imaging (EBBI) of the European Society of Breast Imaging. Dr. Pinker is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Breast Lump, Lymphoid Hyperplasia, Galactocoele, and Lymphofollicular Hyperplasia.

Anil Rustgi is a Medical Genetics specialist and a Gastroenterologist practicing medicine in New York, New York. Dr. Rustgi is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Esophageal Cancer, Barrett Esophagus, Pancreatic Cancer, Endoscopy, and Colonoscopy. Dr. Rustgi is board certified in Gastroenterology. Dr. Rustgi is currently accepting new patients.

Dr. Christine Rohde is the Chief of the Division of Plastic Surgery at Columbia. She graduated from Harvard Medical School in 2000. Following her medical school education, she began her general surgery training at the Brigham and Women’s Hospital in Boston. After three years of general surgery training, Dr. Rohde accepted a plastic and reconstructive surgery residency position at Montefiore Medical Center. Interested in microsurgery, Dr. Rohde completed a microsurgical fellowship at New York University Medical School’s Institute of Reconstructive and Plastic Surgery in 2006. Her research focuses primarily on outcomes of plastic surgical interventions, particularly as they relate to cancer reconstruction and post-surgical care. In 2013, Dr. Rohde graduated from the Columbia University Mailman School of Public Health with a Masters in Public Health, focusing on comparative effectiveness research.A highly skilled clinician, researcher and teacher, Dr. Rohde is trained in the diagnosis and treatment of the full range of plastic reconstructive and aesthetic surgery, specializing in microsurgery, abdominal wall reconstruction, body contouring, cosmetic surgery, and breast, trauma, and cancer reconstruction. She has numerous publications and presentations in the field of plastic surgery, and is a frequently-requested speaker. She has also been seen on the Carol Alt FoxNews Show, “A Healthy You” and WABC, discussing her research and breast cancer reconstruction. Dr. Rohde is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Breast Enlargement In Males, T-Cell Lymphoma, BRCA Positive Breast Cancer, Bone Graft, and Lymphadenectomy. Dr. Rohde is board certified in Plastic Surgery. Dr. Rohde is currently accepting new patients.

Dr. Bret Taback is a nationally recognized surgical oncologist in the New York-Presbyterian/Columbia University Irving Medical Center department of surgery. Dr. Taback is a leader in the clinical management of melanoma, sarcoma and skin/soft tissue tumor surgery. Dr. Taback is the Director of the Melanoma and Sarcoma Program and Director of the Breast Surgery Fellowship. Dr. Taback received his MD degree at Tufts University School of Medicine in Boston , and completed his general surgery residency at Brown University, Rhode Island Hospital. During that time he completed a Basic Science Research Fellowship at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. Following this, he completed a fellowship in Complex Surgical Oncology at the John Wayne Cancer Institute, Santa Monica, California. Dr. Taback is a member of a number of organizations and societies including Society of Surgical Oncology, American Society of Clinical Oncology and the American Association for Cancer Research. He is also a Fellow of the American College of Surgeons. He has published and authored numerous peer review manuscripts, abstracts and presentations, as well as book chapters over the years in notable publications such as Annals of Surgery, Annals of Surgical Oncology, Cancer Research, Clinical Cancer Research and the Journal of the National Cancer Institute. He is a clinical investigator with SWOG and Alliance for clinical trials. Dr. Taback has served on numerous hospital committees including tumor boards, Institutional Review Boards, Oncology Operations Council and is the American College of Surgeon’s Commission on Cancer Physician Liaison for NYP Hospital. Most recently, Dr. Taback is a noted Castle Connolly Top Doctor. Dr. Taback is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Melanoma, Paget Disease of the Breast, Mastectomy, and Lymphadenectomy. Dr. Taback is board certified in Surgery. Dr. Taback is currently accepting new patients.

Jason Wright is an Obstetrics and Gynecologist practicing medicine in New York, New York. Dr. Wright is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Hysterectomy, and Oophorectomy. Dr. Wright is currently accepting new patients.

Eileen Connolly is a Radiation Oncologist practicing medicine in New York, New York. Dr. Connolly is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Triple-Negative Breast Cancer, and HER2 Negative Breast Cancer.